Sue Reichwein
University of Pennsylvania
4 Papers
Sue Reichwein is an academic researcher from University of Pennsylvania. The author has contributed to research in topics: Placebo & Randomized controlled trial. The author has an hindex of 3, co-authored 4 publications.
Chat about Author
Papers
Donepezil for dementia in Parkinson’s disease: a randomised, double blind, placebo controlled, crossover study
Bernard Ravina,Mary E. Putt,Andrew Siderowf,John T. Farrar,M Gillespie,Anthony Crawley,Hubert H. Fernandez,M M Trieschmann,Sue Reichwein,Tanya Simuni +9 more
TL;DR: There may be a modest benefit on aspects of cognitive function in Parkinson’s disease and dementia as reflected in only one of the cognitive scales used in this study.
277
A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease
Karl Kieburtz,Bernard Ravina,Bernard Ravina,Wendy R. Galpern,Barbara C. Tilley,Kathleen M. Shannon,Caroline M. Tanner,G. Frederick Wooten,Robert W. Hamill,Jacob I. Sage,Emily Kosa,Ray L. Watts,Natividad R. Stover,Rebecca McMurray,Mark F. Lew,Connie Kawai,David Coffey,Pauline LeBlanc,Julie H. Carter,Matthew Brodsky,Pamela Andrews,Andrew Siderowf,Sue Reichwein,Lisa M. Shulman,William J. Weiner,Katharine Pabst,Jeana Jaglin,Robert A. Hauser,Theresa McClain,Holly Delgado,Oksana Suchowersky,Lorelei Derwent,Jayaraman Rao,Maureen Cook,Michael J. Aminoff,Chad W. Christine,Jessie Roth,Maureen A. Leehey,Jacci Bainbridge,G. Webster Ross,Stephanie Terashita,Carlos Singer,Marian A. Perez,Anita Blenke,Brad A. Racette,Patricia Deppen,Rodger J. Elble,Charlene Young,Tracy Stewart,Kapil D. Sethi,Buff Dill,John W. Taylor,Peggy Roberge,Richard B. Dewey,Brigid Hayward,Joseph Jankovic,Christine Hunter,Frederick Wooten,Margaret F. Keller,Danna Jennings,Tammie Kelsey,W.R. Wayne Martin,Germaine McInnes,Joanne Wojcieszek,Joann Belden,Roger L. Albin,Kristine Wernette,Joseph M. Savitt,Becky Dunlop,Rajesh Pahwa,Kelly E. Lyons,Amy Parsons,John Y. Fang,Dorothy Shearon,Andrew Feigin,Margaret Marie Cox,Charles H. Adler,Marlene Lind,Burton L. Scott,Joanne Field,Martha Nance,Susan Peterson,Richard S. Burns,Lynn Marlor,I. Van Bodis-Wollner,Elizabeth Hayes,Jay S. Schneider,Stephanie Sendek,Stephen Gollomp,Gwyn Vernon,Peter A LeWitt,Maryan DeAngelis,David Simon,Linda Paul,Jay M. Gorell,Shana Krstevska,Marilyn Flewellen,Sharon McCarthy,Ryan J. Uitti,Margaret F. Turk,James H. Bower,Susan Torgrimson,Marwan N. Sabbagh,Zoran Obradov,Jorge L. Juncos,Mary Louise Musante Weeks,Hubert H. Fernandez,Gordon H. Brown,Jordan J. Elm,Paulo Guimaraes,Peng Huang,Yuko Y. Palesch,Cornelia Kamp,Aileen Shinaman,Debbie Fraser,Alicia Brocht,Susan Bennett,Chris Weaver,Debbie Baker,Beverly Olsen,Christopher G. Goetz,Janis M. Miyasaki,Susan C. Fagan,Patrick D. Mauldin +123 more
TL;DR: Coenzyme Q10 and GPI-1485 may warrant further study in Parkinson disease, although the data are inconsistent, and additional factors should be considered in the selection of agents for Phase III studies.
225
Effect of Creatine Monohydrate on Clinical Progression in Patients With Parkinson Disease A Randomized Clinical Trial
Karl Kieburtz,Barbara C. Tilley,Jordan J. Elm,Debra Babcock,Robert A. Hauser,G. Webster Ross,Alicia H. Augustine,Erika U. Augustine,Michael J. Aminoff,Ivan Bodis-Wollner,James T. Boyd,Franca Cambi,Kelvin L. Chou,Chadwick W. Christine,Michelle Cines,Nabila Dahodwala,Lorelei Derwent,Richard B. Dewey,Katherine B. Hawthorne,David J. Houghton,Cornelia Kamp,Maureen A. Leehey,Mark F. Lew,Grace S. Liang,Sheng Luo,Zoltan Mari,John C. Morgan,Sotirios A. Parashos,Adriana Pérez,Helen Petrovitch,Suja S. Rajan,Sue Reichwein,Jessie Roth,Jay S. Schneider,Kathleen M. Shannon,David Simon,Tanya Simuni,Carlos Singer,Lewis Sudarsky,Caroline M. Tanner,Chizoba C. Umeh,Karen Williams,Anne-Marie Wills +42 more
TL;DR: Among patients with early and treated Parkinson disease, treatment with creatine monohydrate for at least 5 years, compared with placebo did not improve clinical outcomes, and these findings do not support the use of creatine mon carbohydrate in patients with Parkinson disease.
199